News search

E.g., 19/07/2026
E.g., 19/07/2026
Diana Velázquez, Natalia Vicente, Jon Sicilia, María Rosaria Pricolo, Laura Sen, Jorge Alegre y Agata Bak.
Research
7 Jul 2026

Hypertrophic cardiomyopathy is the most common inherited heart disease and the leading cause of sudden cardiac death in young people and athletes

Optimal dendritic-cell-based antitumor immunotherapy with cDC1 cells requires active mitochondria. Whereas vaccination with normal cDC1 cells efficiently reduces metastasis in B16-OVA tumors, the antitumor efficacy of these cells is diminished when their mitochondria are damaged.
Research
22 May 2026

CNIC-led study identifies a mitochondrial “checkpoint” that enables dendritic cells to efficiently activate T lymphocytes against viruses and tumors

Francesco Costa
Anthony Firulli
From left to right, Borja Ibáñez, Laura Cádiz, Agustín Clemente Moragón, Ángela Pollán, Lucía López Palomar, and Anabel Díaz Guerra.
Research
26 Feb 2026

The study shows that a simple, non-pharmacological technique known as remote ischemic conditioning (RIC) can protect the heart during treatment with anthracyclines

Raquel Martínez de Meno, Rebeca Acín Pérez, José Antonio Enríquez, Sara Jaroszewicz y Rebeca Sanz-Cortés.
Research
16 Feb 2026

A new CNIC-led study shows that a genetic tool derived from baker’s yeast enables human cells to manufacture the building blocks of DNA even when their mitochondria fail.

Ana Simón Chica y David Filgueiras Rama
Research
10 Feb 2026

The study, published in Circulation Research, identifies cardiac fibroblasts and resident macrophages as essential contributors to the characteristic electrical activity that maintains this arrhythmia

Foto
Research
5 Feb 2026

prespecified landmark analysis of the REBOOT trial, published in The European Heart Journal Cardiovascular Pharmacotherapy, shows no clinical benefit of beta-blockers during the first year after infarction or beyond one year, in patients without reduced ejection fraction.

call for applications
About the CNIC
3 Feb 2026

The CNIC is opening a public call for entries for visual works, until 15 February, aimed at artists who wish to participate with works in disciplines such as photography, painting, sculpture and mixed media

From left to right: Miguel Sánchez Álvarez, Miguel Ángel del Pozo, David Sancho, Ignacio Heras Murillo, Gillian Dunphy, Aitor Jarit Cabanillas, Elena Moya Ruiz, Irene Adán Barrientos
Research
28 Jan 2026

study published in Immunity reveals that type I interferons (IFN‑I) help resolve inflammation by inducing changes in macrophage mitochondria